Health IT Analytics March 1, 2021
Researchers used a novel approach to understand hypertrophic cardiomyopathy beyond the identification of individual genes, potentially leading to precision medicine therapies.
An innovative approach helped researchers analyze the role of protein-protein interactions (PPIs) in cases of hypertrophic cardiomyopathy (HCM), a discovery that could advance precision medicine treatments for the heart condition, according to a study published in Nature Communications.
HCM is a cardiovascular disease characterized by thickening of the left ventricle, known as the main squeezing chamber of the heart. HCM is known for causing sudden death in athletes but can occur in individuals of any age, typically without symptoms.
Although the condition is frequently discussed in the context of genetics, most patients with HCM don’t have a known genetic...
Today's Sponsors
Today's Sponsor